The invention concerns compounds which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)-ones.
本发明涉及抑制MEK并具有抗肿瘤活性的化合物,其中包括N-取代的3-羟基-5-芳基
氨基
异噻唑-4-羧
酰胺类化合物。还包括互变
异噻唑-3(2H)-酮。